Form 8-K - Current report:
SEC Accession No. 0001193125-23-050813
Filing Date
2023-02-27
Accepted
2023-02-27 16:27:03
Documents
14
Period of Report
2023-02-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d372195d8k.htm   iXBRL 8-K 30330
2 EX-10.1 d372195dex101.htm EX-10.1 26264
3 EX-10.2 d372195dex102.htm EX-10.2 95095
  Complete submission text file 0001193125-23-050813.txt   305528

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230221.xsd EX-101.SCH 2871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230221_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230221_pre.xml EX-101.PRE 11275
8 EXTRACTED XBRL INSTANCE DOCUMENT d372195d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 23675334
SIC: 2834 Pharmaceutical Preparations